McMagyar on ihub (post # 73389) provides the following surmise re 9 month Part B update:
Week 1 November 1, 38 week ended July 22nd. Perhaps new news is coming sooner than we may think!
Good point. Dementia costs upwards of $100 billion a year, of which, AD is a major component. Once the pathways are open for cross-applications, many promising medical interventions will follow.
Law suits bogus (So tell us something we didn't already know. Still good news to get this out of the way). $.06 cents vs over 20 cents in expenses, more good news. New catalysts in the wings. Anyone able to compute the "nine month" timeline?
Nice catch. One of the main points I gathered is: Wait until optimal dosage is given through the next leg of trial! Current dosages were all over the map trying to figure what dosage works best for each patient; and we STILL maintained cognitive stability. Very encouraging.
Sentiment: Strong Buy
Your question is ambiguous. I evaluate what the company reported prior to the AAIC and what was presented at the convention. Company spoke in general terms about encouraging news before and after conference. They never offered specific scores prior to conference (not permitted) and provided information at the conference confirming stability in a degenerating disease. It's all quite routine from my experience; expectations from investors tainted actual data release (I don't particularly blame the fervor as it is to be expected).
Sentiment: Strong Buy
I ask one question daily: Would I want to be invested in this stock at this price right now? Answer: YES! I also consider whether the prospects of the company have been materially and negatively impacted. The answer is no; SOC is better and catalysts in the wings.
Added some Jan calls and in a good position to profit from a nice rebound.
cnafinance.com nailed it today with the above article. A must read. When dust settles tomorrow or the next day, will acquire some January calls to add to my position. Haven't seriously posted in a while but felt compelled to do so after this orchestrated attack. As most of you know, I have no hesitancy in bailing on a stock if news is LEGITIMATELY negative. I have sold and lost before am not naive enough to try and recover what are considered by economists as "sunken costs." This stock will see another day and current price is generously discounted.